SCHEMBL15712245

SCHEMBL15712245

COC(=O)c1cc(-c2cccnc2)ccc1Nc1ccc2c(ccn2Cc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB4 Q15303 3/20 0.47
EGFR P00533 2/20 0.47
NTSR1 P30989 1/20 0.47
NR4A2 P43354 2/20 0.46
P2RX7 Q99572 1/20 0.46
ERBB2 P04626 3/20 0.45
MAOB P27338 2/20 0.44
CYP11B1 P15538 3/20 0.43
CYP11B2 P19099 3/20 0.43
CYP19A1 P11511 1/20 0.42
KDM4E B2RXH2 1/20 0.42
SYK P43405 1/20 0.41
CDK1 P06493 1/20 0.41
CDK4 P11802 1/20 0.41
CCNB1 P14635 1/20 0.41
CCND1 P24385 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
CDK6 Q00534 1/20 0.41
CDK5 Q00535 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15712246 0.91 NTSR1 (0.47) ERBB4EGFRNTSR1P2RX7ERBB2
SCHEMBL15712361 0.91 ERBB2 (0.47) ERBB4EGFRNTSR1NR4A2ERBB2
SCHEMBL15712470 0.86 ERBB4 (0.52) ERBB4EGFRERBB2MAOBKDM4E
SCHEMBL15712210 0.83 ERBB2 (0.48) ERBB4EGFRP2RX7ERBB2SYK
SCHEMBL15712122 0.83 ERBB2 (0.48) ERBB4EGFRP2RX7ERBB2SYK
SCHEMBL15712358 0.82 ERBB2 (0.48) ERBB4EGFRNTSR1ERBB2SYK
SCHEMBL15712256 0.81 ERBB2 (0.46) ERBB4EGFRNTSR1P2RX7ERBB2
SCHEMBL15712533 0.80 KCNQ3 (0.53) ERBB4EGFRP2RX7ERBB2SYK
SCHEMBL15712370 0.79 ERBB2 (0.47) ERBB4EGFRERBB2SYKCDK1
SCHEMBL15712824 0.78 EGFR (0.48) ERBB4EGFRERBB2MAOBSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2915804-B1 NOVEL AMINE DERIVATIVE OR SALT THEREOF AS TNF ALPHA INHIBITORS FUJIFILM TOYAMA CHEMICAL CO LTD (JP) 2019-03-27 EP disclosed
EP-2915804-B1 NOVEL AMINE DERIVATIVE OR SALT THEREOF AS TNF ALPHA INHIBITORS FUJIFILM TOYAMA CHEMICAL CO LTD (JP) 2019-03-27 EP disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
EP-2915804-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2015-09-09 EP disclosed
WO-2014069510-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF HRH4, CLIC4, KRT18 ERBB4 786/4885EGFR 537/4885NTSR1 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.